Hereditary diffuse gastric cancer associated with a novel germline variant c.1596G>A in the CDH1 gene

Gastric cancer is one of the most common malignancies worldwide. Approximately 10 % of patients with gastric cancer are characterized by accumulation of gastric cancer cases in their family. The hereditary forms of gastric cancer account for 1–3 % of all gastric cancer cases. Hereditary diffuse GC syndrome is caused by germline mutations in CDH1 gene and determines a high risk of developing diffuse GC and lobular breast cancer. In this article, we present a clinical case of a 41-year-old patient with diffuse gastric cancer, who was found to be a carrier of novel germline mutation in the CDH1 gene. Next-generation sequencing (NGS) has facilitated an identification of CDH1 c.1596G>A genetic variant, thus enabling an accurate clinical diagnosis hereditary diffuse gastric cancer.

1. Состояние онкологической помощи населению России в 2021 году. Под ред. А.Д. Каприна, В.В. Старинского, О.А. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. 239 с. Malignant neoplasms in Russia in 2021. Ed. by A.D. Kaprin, V.V. Starisnky, О.А. Shahzadova. Moscow: P. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 2022. 239 p. (In Russ.).

2. Van der Post R.S., Vogelaar I.P., Carneiro F. et al. Hereditary diffuse gastric cancer: Updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 2015;52(6): 361–74. DOI: 10.1136/JMEDGENET-2015-103094

3. Assumpção P., Araújo T., Khayat A. et al. Hereditary gastric cancer: three rules to reduce missed diagnoses. World J Gastroenterol 2020;26(13):1382–93. DOI: 10.3748/WJG.V26.I13.1382

4. Setia N., Clark J.W., Duda D.G. et al. Gastrointestinal cancer familial gastric cancers. Oncologist 2015;20(12):1365–77. DOI: 10.1634/theoncologist.2015-0205

5. Hansford S., Kaurah P., Li-Chang H. et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol 2015;1(1):23–32. DOI: 10.1001/JAMAONCOL.2014.168

6. Lobo S., Benusiglio P.R., Coulet F. et al. Cancer predisposition and germline CTNNA1 variants. Eur J Med Genet 2021;64(10):104316. DOI: 10.1016/J.EJMG.2021.104316

7. Godwin T.D., Kelly S.T., Brew T.P. et al. E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function. Gastric Cancer 2019;22(2):273–86. DOI: 10.1007/S10120-018-0859-1

8. Paredes J., Figueiredo J., Albergaria A. et al. Epithelial E- and Pcadherins: role and clinical significance in cancer. Biochim Biophys Acta 2012;1826(2):297–311. DOI: 10.1016/j.bbcan.2012.05.002

9. Lo W., Zhu B., Sabesan A. et al. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). J Med Genet 2019;56(6):370–9. DOI: 10.1136/jmedgenet-2018-105361

10. Grady W.M., Willis J., Guilford P.J. et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 2000;26(1):16–7. DOI: 10.1038/79120

11. Hansford S., Kaurah P., Li-Chang H. et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol 2015;1(1):23–32. DOI: 10.1001/JAMAONCOL.2014.168

12. Kaurah P., MacMillan A., Boyd N. et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007;297(21):2360–72. DOI: 10.1001/JAMA.297.21.2360

13. Van der Post R.S., Gullo I., Oliveira C. et al. Histopathological, molecular, and genetic profile of hereditary diffuse gastric cancer: current knowledge and challenges for the future. Adv Exp Med Biol 2016;908:371–91. DOI: 10.1007/978-3-319-41388-4_18

14. Pharoah P.D.P., Guilford P., Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001;121(6):1348–53. DOI: 10.1053/gast.2001.29611

15. Абрамов И.С., Лисица Т.С., Строганова А.М. и др. Диагностика наследственных опухолевых синдромов методом высокопроизводительного секвенирования. Опыт создания базы данных. Клиническая практика 2021;12(2):36–42. DOI: 10.17816/ clinpract76383 Abramov I.S., Lisitsa T.S., Stroganova A.M. et al. Diagnostics of hereditary cancer syndromes by NGS. Process of creating a database. Klinicheskaya praktika = Clinical practice 2021;12(2): 36–42. (In Russ.). DOI: 10.17816/clinpract76383

16. Oliveira C., Senz J., Kaurah P. et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009;18(9):1545–55. DOI: 10.1093/hmg/ddp046

17. Hoang T., Ganesan A., Hiyama D. et al. Gene mutations distinguishing gastric from colorectal and esophageal adenocarcinomas. J Gastrointest Oncol 2020;11(1):45–54. DOI: 10.21037/jgo.2019.12.06

18. Melo S., Figueiredo J., Fernandes M.S. et al. Predicting the functional impact of CDH1 missense mutations in hereditary diffuse gastric cancer. Int J Mol Sci 2017;18(12):1–18. DOI: 10.3390/ ijms18122687

19. Blair V.R., McLeod M., Carneiro F. et al. Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 2020;21(8):38697. DOI: 10.1016/S1470-2045(20)30219-9

20. Gullo I., Devezas V., Baptista M. et al. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with earlyonset disease. Gastrointest Endosc 2018; 87(6):1566–75. DOI: 10.1016/j.gie.2018.02.008

21. Yasmeen A., Bismar T., Moustafa A. et al. ErbB receptors and complex in human carcinomas. Future Oncol 2006;2(6):765–81. DOI: 10.2217/14796694.2.6.765

22. Benusiglio P.R., Malka D., Rouleau E. et al. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 2013;50(7):486–9. DOI: 10.1136/JMEDGENET-2012-101472

23. Mastracci T.L., Tjan S., Bane A.L. et al. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol 2005;18(6):741–51. DOI: 10.1038/ modpathol.3800362

24. Jacobs M.F., Dust H., Koeppe E. et al. Outcomes of endoscopic surveillance in individuals with genetic predisposition to hereditary diffuse gastric cancer. Gastroenterology 2019;157(1):87–96. DOI: 10.1053/J.GASTRO.2019.03.047

25. Lowstuter K., Espenschied C.R., Sturgeon D. et al. Unexpected CDH1 mutations identified on multigene panels pose clinical management challenges. JCO Precis Oncol 2017;(1):1–12. DOI: 10.1200/PO.16.00021

26. Ford J.M. Totally unexpected: nonsyndromic CDH1 mutations and hereditary diffuse gastric cancer syndrome. JCO Precis Oncol 2017;1:1–2. DOI: 10.1200/po.17.00006